ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $14,538,000 | +3130.7% | 313,796 | +893.7% | 0.09% | +3000.0% |
Q4 2018 | $450,000 | -95.0% | 31,579 | -94.7% | 0.00% | -92.7% |
Q3 2018 | $8,975,000 | +1298.0% | 595,888 | +1458.0% | 0.04% | +1266.7% |
Q2 2018 | $642,000 | -87.6% | 38,248 | -88.0% | 0.00% | -86.4% |
Q1 2018 | $5,183,000 | -77.8% | 317,608 | -82.6% | 0.02% | -69.9% |
Q4 2017 | $23,332,000 | +452.1% | 1,822,804 | +430.6% | 0.07% | +329.4% |
Q3 2017 | $4,226,000 | -29.8% | 343,559 | -52.2% | 0.02% | -32.0% |
Q2 2017 | $6,019,000 | -7.6% | 719,124 | -1.4% | 0.02% | -19.4% |
Q1 2017 | $6,517,000 | -46.7% | 729,000 | -47.5% | 0.03% | -53.0% |
Q4 2016 | $12,216,000 | +10615.8% | 1,389,775 | +4230.9% | 0.07% | +6500.0% |
Q2 2016 | $114,000 | -22.4% | 32,090 | -35.5% | 0.00% | 0.0% |
Q1 2016 | $147,000 | -27.9% | 49,790 | +3.0% | 0.00% | 0.0% |
Q4 2015 | $204,000 | -36.4% | 48,360 | -31.4% | 0.00% | -50.0% |
Q3 2015 | $321,000 | -39.2% | 70,450 | -3.7% | 0.00% | -33.3% |
Q2 2015 | $528,000 | -94.6% | 73,190 | -96.5% | 0.00% | -97.3% |
Q1 2014 | $9,732,000 | +61.6% | 2,070,626 | +72.2% | 0.11% | +42.3% |
Q4 2013 | $6,023,000 | -13.0% | 1,202,200 | +8.0% | 0.08% | -16.1% |
Q3 2013 | $6,921,000 | +173.2% | 1,112,684 | +99.4% | 0.09% | +116.3% |
Q2 2013 | $2,533,000 | – | 557,940 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |